Prevention and Control of Healthcare-Associated Infections

The recruitment status of this study is unknown because the information has not been verified recently.

Verified June 2009 by Mahidol University.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

Mahidol University

ClinicalTrials.gov Identifier:

NCT00917319

First received: June 5, 2009

Last updated: June 16, 2009

Last verified: June 2009

History of Changes

Purpose

Bundling infection control interventions should decrease incidence of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand

Condition	Intervention
Nosocomial Infection	Other: Bundling Infection Control Interventions

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention
Official Title:	Randomized Controlled Study on Effectiveness of Implementing Bundling Infection Control Interventions for Prevention and Control of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand

Resource links provided by NLM:

MedlinePlus related topics: Infection Control

U.S. FDA Resources

Further study details as provided by Mahidol University:

Primary Outcome Measures:

Incidence of healthcare-associated infection [ Time Frame: 7 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Incidence of hospital-acquired pneumonia and catheter-associated UTI [ Time Frame: 7 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	2000
Study Start Date:	January 2009
Estimated Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Infection control measure Bundling Infection Control Interventions	Other: Bundling Infection Control Interventions identify risk factors for developing HAIs, receive general infection control measures as well as infection control measures appropriate for the identified risk factor (s)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

The patients hospitalized to general medical wards

Exclusion Criteria:

The patients hospitalized less than 48 hours

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00917319

Locations

Thailand
Department of Medicine, Faculty of Medicine Siriraj Hospital
Bangkoknoi,, Bangkok, Thailand, 10700

Sponsors and Collaborators

Mahidol University

Investigators

Principal Investigator:

Visanu Thamlikitkul, MD

Siriraj Hospital

More Information

No publications provided by Mahidol University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Korbkitjaroen M, Vaithayapichet S, Kachintorn K, Jintanothaitavorn D, Wiruchkul N, Thamlikitkul V. Effectiveness of comprehensive implementation of individualized bundling infection control measures for prevention of health care-associated infections in general medical wards. Am J Infect Control. 2011 Aug;39(6):471-6. Epub 2011 May 12.

Responsible Party:	Visanu Thamlikitkul, Siriraj Hospital
ClinicalTrials.gov Identifier:	NCT00917319 History of Changes
Other Study ID Numbers:	Siriraj CEU 52-001, Siriraj Hospital
Study First Received:	June 5, 2009
Last Updated:	June 16, 2009
Health Authority:	Thailand: Ethical Committee

Additional relevant MeSH terms:

Cross Infection
Infection

ClinicalTrials.gov processed this record on May 16, 2013

To Top